IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection

Scandinavian Journal of Immunology

Volumn 81, Issue 6, 2015, Pages 494-501

  Zeng, S ^a   Wu, J ^b   Liu, J ^a   Qi, F ^a   Liu, B ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 33; CYTOKINE; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-33, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; GENE EXPRESSION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; LIGAND BINDING; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; TARGET CELL; TH17 CELL; TH2 CELL; UPREGULATION; VIRAL CLEARANCE; VIROGENESIS; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD45; CELL LINE, TUMOR; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTERLEUKINS; LUNG; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84929192798     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12284     Document Type: Article

References (35)

1. Gupta S, Shamsundar R, Shet A, Chawan R, Srinivasa H. Prevalence of respiratory syncytial virus infection among hospitalized children presenting with acute lower respiratory tract infections. Indian J Pediatr 2011;78:1495-7.
2. González PA, Bueno SM, Carreño LJ, Riedel CA, Kalergis AM. Respiratory syncytial virus infection and immunity. Rev Med Virol 2012;22:230-44.
3. Lukacs NW, Tekkanat KK, Berlin A et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001;167:1060-5.
4. Everard ML. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Curr Opin Allergy Clin Immunol 2006;6:56-61.
5. Bueno SM, González PA, Pacheco R et al. Host immunity during RSV pathogenesis. Int Immunopharmacol 2008;8:1320-9.
6. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
7. Yasuda K, Muto T, Kawagoe T et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. PNAS 2012;109:3451-6.
8. Kamijo S, Takeda H, Tokura T et al. IL-33-mediated innate response and adaptive immune cells contribute to the maximum response of protease allergen-induced allergic airway inflammation. J Immunol 2013;190:4489-99.
9. Klein Wolterink RG, Kleinjan A, van Nimwegen M et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 2012;42:1106-16.
10. Hardman CS, Panova V, McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013;43:488-98.
11. Kondo Y, Yoshimoto T, Yasuda K et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008;20:791-800.
12. Kurowska-Stolarska M, Kewin P, Murphy G et al. IL-33 induces antigen-specific IL-5 + T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 2008;181:4780-90.
13. Kurowska-Stolarska M, Stolarski B, Kewin P et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009;183:6469-77.
14. Morita H, Arae K, Ohno T et al. ST2 requires Th2-, but not Th17-, type airway inflammation in epicutaneously antigen- sensitized mice. Allergol Int 2012;61:265-73.
15. Kearley J, Buckland KF, Mathie SA, Lloyd CM. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 2009;179:772-81.
16. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009;386:181-5.
17. Mizutani N, Nabe T, Yoshino S. IL-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodeling in mice. Immunology 2013;139:205-18.
18. Gavala ML, Bashir H, Gern JE. Virus/allergen interactions in asthma. Curr Allergy Asthma Rep 2013;13:298-307.
19. Liu B, Kimura Y. Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J Gen Virol 2007;88:2552-8.
20. Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells medicate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011;12:631-8.
21. Le Goffic R, Arshad MI, Rauch M et al. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol 2011;45:1125-32.
22. Oh K, Seo MW, Lee GY et al. Airway epithelial cells initiate the allergen response through transglutaminase 2 by inducing IL-33 expression and a subsequent Th2 response. Respir Res 2013;14:35.
23. Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 1993;318:83-7.
24. Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994;13:1176-88.
25. Rössler U, Thomassen E, Hültner L, Baier S, Danescu J, Werenskiold AK. Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1-binding proteins, are differently expressed in vivo. Dev Biol 1995;168:86-97.
26. Löhning M, Grogan JL, Coyle AJ et al. T1/ST2 expression is enhanced on CD4 + T cells from schistosome egg-induced granulomas: analysis of Th cell cytokine coexpression ex vivo. J Immunol 1999;162:3882-9.
27. Coyle AJ, Lloyd C, Tian J et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999;190:895-902.
28. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000;106:551-9.
29. Walzl G, Matthews S, Kendall S et al. Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med 2001;193:785-92.
30. Castilow EM, Meyerholz DK, Varga SM. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. J Immunol 2008;180:2376-84.
31. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009;2:403-11.
32. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007;179:2051-4.
33. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010;185:3472-80.
34. Besnard AG, Togbe D, Guillou N, Erard F, Quesniaux V, Ryffel B. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 2011;41:1675-86.
35. Kim HY, Chang YJ, Subramanian S et al. Innate lymphoid cells responding to IL-33 medicate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 2012;129:216-27.